INOVIO PHARMACEUTICALS INC's ticker is and the CUSIP is 45773H901. A total of 3 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $1,734 | -10.8% | 3,400 | -32.0% | 0.00% | – |
Q3 2023 | $1,945 | -63.7% | 5,000 | -58.3% | 0.00% | – |
Q2 2023 | $5,358 | -84.0% | 12,000 | -70.6% | 0.00% | – |
Q1 2023 | $33,456 | -70.2% | 40,800 | -43.3% | 0.00% | – |
Q4 2022 | $112,320 | -39.0% | 72,000 | -32.6% | 0.00% | – |
Q3 2022 | $184,000 | -7.5% | 106,800 | -7.2% | 0.00% | – |
Q2 2022 | $199,000 | -72.6% | 115,100 | -43.0% | 0.00% | -100.0% |
Q1 2022 | $725,000 | -69.2% | 201,900 | -57.3% | 0.00% | -50.0% |
Q4 2021 | $2,357,000 | -46.2% | 472,400 | -22.9% | 0.00% | -60.0% |
Q3 2021 | $4,385,000 | -16.5% | 612,400 | +8.1% | 0.01% | -16.7% |
Q2 2021 | $5,251,000 | -5.5% | 566,400 | -5.4% | 0.01% | -25.0% |
Q1 2021 | $5,555,000 | +2.0% | 598,600 | -2.7% | 0.01% | -11.1% |
Q4 2020 | $5,446,000 | -62.3% | 615,400 | -50.6% | 0.01% | -80.0% |
Q3 2020 | $14,443,000 | -47.7% | 1,245,100 | +21.6% | 0.04% | -64.6% |
Q2 2020 | $27,605,000 | +179.3% | 1,024,300 | -22.9% | 0.13% | +58.8% |
Q1 2020 | $9,884,000 | +17870.9% | 1,328,500 | +7903.0% | 0.08% | – |
Q4 2019 | $55,000 | +358.3% | 16,600 | +176.7% | 0.00% | – |
Q3 2019 | $12,000 | -90.9% | 6,000 | -86.6% | 0.00% | -100.0% |
Q2 2019 | $132,000 | +214.3% | 44,800 | +300.0% | 0.00% | – |
Q1 2019 | $42,000 | -66.4% | 11,200 | -64.2% | 0.00% | -100.0% |
Q4 2018 | $125,000 | -9.4% | 31,300 | +26.2% | 0.00% | 0.0% |
Q3 2018 | $138,000 | +100.0% | 24,800 | +40.1% | 0.00% | 0.0% |
Q2 2018 | $69,000 | -70.0% | 17,700 | -63.8% | 0.00% | -50.0% |
Q1 2018 | $230,000 | +85.5% | 48,900 | +63.0% | 0.00% | +100.0% |
Q4 2017 | $124,000 | -86.7% | 30,000 | -79.5% | 0.00% | -87.5% |
Q3 2017 | $929,000 | +469.9% | 146,500 | +604.3% | 0.01% | +300.0% |
Q2 2017 | $163,000 | +207.5% | 20,800 | +160.0% | 0.00% | +100.0% |
Q1 2017 | $53,000 | -97.5% | 8,000 | -97.4% | 0.00% | -95.2% |
Q4 2016 | $2,135,000 | -31.1% | 307,700 | -7.4% | 0.02% | -38.2% |
Q3 2016 | $3,097,000 | -3.8% | 332,300 | -4.6% | 0.03% | -10.5% |
Q2 2016 | $3,219,000 | +89.6% | 348,400 | +78.7% | 0.04% | +58.3% |
Q1 2016 | $1,698,000 | +444.2% | 195,000 | +320.3% | 0.02% | +500.0% |
Q4 2015 | $312,000 | -16.4% | 46,400 | -28.2% | 0.00% | -20.0% |
Q3 2015 | $373,000 | -7.0% | 64,600 | +31.3% | 0.01% | -16.7% |
Q2 2015 | $401,000 | +30.2% | 49,200 | +30.5% | 0.01% | +20.0% |
Q1 2015 | $308,000 | -77.3% | 37,700 | -74.5% | 0.01% | -75.0% |
Q4 2014 | $1,357,000 | -59.4% | 147,800 | -56.5% | 0.02% | -60.8% |
Q3 2014 | $3,343,000 | – | 339,400 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|